SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.

Advertisement


Inside Views

Submit ideas to info [at] ip-watch [dot] ch!

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

To What Extent Can Global IP Rules Be Responsive To Public Interest Demands? The Case Of The Treaty For The Visually Impaired

To what extent can global intellectual property rules address in an effective manner the needs of the most vulnerable members of society? This is the key question with which member states of the World Intellectual Property Organization (WIPO) are faced as they prepare to meet next week for a diplomatic conference, in Marrakesh, that should result in the adoption of a treaty to facilitate access to copyrighted works by visually impaired persons and persons with print disabilities.


Interview With Tanja Rajić: The Impact Of EU Enlargement On Trademark Practice In Croatia

Ten years after applying for membership, Croatia is finally joining the European Union on 1 July 2013. Tanja Rajić, senior associate at PETOSEVIC, explains how six years of accession negotiations and the adoption of the acquis communautaire have affected intellectual property protection in Croatia and prepared it for becoming a member state.





Latest Comments
  • We in India should not change our policy, speciall... »
  • We in India should not change our policy, speciall... »

  • For IPW Subscribers
    A directory of IP delegates in Geneva. Read more>

    A guide to Geneva-based public health and intellectual property organisations. Read More >

    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >


    WHO

    09/01/2013: IP-Watch Looks At The Year Ahead In International IP Policy
    29/11/2012: WHO Members Agree On “Strategic Work Plan” On Health R&D – But No Convention
    29/11/2012: WHO Negotiations To Address Medical R&D Global Gaps Head Deep Into Night
    28/11/2012: International Instrument On Medical R&D Still On Negotiating Table At WHO
    27/11/2012: UNITAID: Alternative Funding Mechanism For AIDS Drugs Saving Lives
    25/11/2012: WHO Members Meet This Week To Address Global Gaps In Medical R&D
    22/11/2012: WHO Members Agree On Roadmap To Fight Poor Quality Medicines
    20/11/2012: WTO Dispute Body Hears Sides On Australia Tobacco Law
    19/11/2012: WHO Denies Industry Money Unduly Influencing Noncommunicable Disease Fight
    15/11/2012: Global Fund Names Mark Dybul Executive Director
    14/11/2012: Recent Research Highlights Potential Of Open Access In Drug Discovery
    14/11/2012: Medicines Patent Pool Names New Director
    09/11/2012: Study Shows Drug Patents Can Be Extended For Decades
    09/11/2012: WHO Negotiations On Global Monitoring Framework Seen As Success In Noncommunicable Disease Fight
    09/11/2012: Technical Meeting Advances Ideas For WHO-Led R&D Financing Framework
    01/11/2012: Pharma Outlook: Don’t Yield On IP, Work On Trust-Building, Call For Global Cooperation
    23/10/2012: WHO Member States Hammering Out Details On Noncommunicable Diseases
    16/10/2012: Open-Access Journal eLife Publishes First Articles
    16/10/2012: New WHO Mechanism Against Poor Quality Medicines To Convene In Buenos Aires
    15/10/2012: Global Fund Nears Selection Of New Director For Transformed Organisation
    15/10/2012: Panellists: Global Health Justice Needs Government Commitment, New Innovation Models
    08/10/2012: At WHO, Pharma Suggests Payment Plan For Influenza Virus Use
    02/10/2012: MSF Launches Patent Opposition Database
    24/09/2012: A Look At Who’s Who In Geneva IP Policymaking And Beyond
    21/09/2012: Decision on WIPO Design Treaty Left To General Assembly; Internet Issue Dropped
    12/09/2012: IFPMA Report, Panel, Examine Rise Of Industry Global Health Partnerships
    30/08/2012: Silberschmidt To Join WHO As Senior Adviser To Director General
    15/08/2012: WHO Hopes For “Domino Effect” Of Australian Ruling In Favour Of Tobacco Plain Packaging
    28/07/2012: Global Pharma Calls On ICANN To Act Against Online Counterfeits
    02/07/2012: WHO Report Details Accountability In Director Chan’s First Term
    28/06/2012: Licensing, Generic Competition Needed To Drive Down HIV Drug Prices, Speakers Say
    21/06/2012: If You Can’t Join ‘Em, Beat ‘Em: New Industry Effort A Jab At Patent Pool?
    20/06/2012: WHO Paper: How To Guard Against Tobacco Companies – And Trade Law
    30/05/2012: Governments, WHO, Reveal Industry’s Back-Channel Battle Against Tobacco Legislation
    28/05/2012: World Health Assembly: WHO Carves Out Leadership Role In “Vaccine Decade”
    26/05/2012: World Health Assembly: Member States Call For Acceleration On Pandemic Flu Preparedness
    26/05/2012: World Health Assembly: Members Gavel New Mechanism To Fight Poor-Quality Medicines
    25/05/2012: World Health Assembly: Agreement Reached On Neglected Disease R&D Process, But No Convention
    25/05/2012: World Health Assembly: Members Adopt Resolution On Preventing And Controlling NCDs
    25/05/2012: World Health Assembly: Latest Texts Of R&D Drafting Group
    24/05/2012: World Health Assembly: R&D Drafting Group Documents Show Country Differences
    24/05/2012: World Health Assembly Draft Decision On NCDs
    24/05/2012: World Health Assembly: Drafting Group Works To Combine Proposals On R&D
    22/05/2012: WHO Members To Address Proposals For Financing Developing Country R&D
    22/05/2012: Nobel Laureate, Other Experts Hail WHO Effort On Medicines R&D Framework
    21/05/2012: WHO Director Chan Opens Annual Assembly With Optimism, Despite Economic Woes
    19/05/2012: Drug Safety Needs Global Cooperation Of Drug Regulators, Officials Say
    11/05/2012: DNDi Backs WHO ‘Neglected Patients’ R&D Treaty
    10/05/2012: New IFPMA-Backed Report On R&D For Diseases In Developing Countries
    03/05/2012: Draft Proposal Calls For Delay Of WHO R&D Treaty Talks
    Your IP address is 54.242.233.11